Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Rudnick

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Investigative Radiology|January 1, 1985
The radiologic diagnosis of pancreatic cancer. The effect of new imaging techniquesB C Yankaskas, E V Staab, S A Rudnick, et al.
Clinical Pharmacology and Therapeutics|February 1, 1980
Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicideM S Kramer, T A Hutchinson, S A Rudnick, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferonS Martino, V Ratanatharathorn, C Karanes, et al.
Annals of Internal Medicine|July 1, 1985
Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancersJ M Kirkwood, M S Ernstoff, C A Davis, et al.
The Journal of Urology|February 1, 1988
Phase I/II study of recombinant interferon gamma in advanced renal cell carcinomaM B Garnick, S D Reich, B Maxwell, et al.
Transplantation|October 1, 1991
OKT3E, an anti-CD3 antibody that does not elicit side effects or antiidiotype responses in chimpanzeesP E Rao, G Olini, J Kille, et al.
Cancer|October 1, 1979
High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaS A Rudnick, E C Cadman, R L Capizzi, et al.
Gastrointestinal Endoscopy|November 1, 1982
Use of the flexible sigmoidoscope in women with previous pelvic irradiationR S Sandler, V Varma, C A Herbst, et al.
The New England Journal of Medicine|July 24, 1980
Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factorsP A Aronin, M S Mahaley, S A Rudnick, et al.
Cancer|March 15, 1983
High-dose methotrexate in small cell lung cancer. Lack of efficacy in preventing CNS relapseE S Neijstrom, R L Capizzi, S A Rudnick, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Investigative Radiology|January 1, 1985
The radiologic diagnosis of pancreatic cancer. The effect of new imaging techniquesB C Yankaskas, E V Staab, S A Rudnick, et al.
Clinical Pharmacology and Therapeutics|February 1, 1980
Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicideM S Kramer, T A Hutchinson, S A Rudnick, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferonS Martino, V Ratanatharathorn, C Karanes, et al.
Annals of Internal Medicine|July 1, 1985
Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancersJ M Kirkwood, M S Ernstoff, C A Davis, et al.
The Journal of Urology|February 1, 1988
Phase I/II study of recombinant interferon gamma in advanced renal cell carcinomaM B Garnick, S D Reich, B Maxwell, et al.
Transplantation|October 1, 1991
OKT3E, an anti-CD3 antibody that does not elicit side effects or antiidiotype responses in chimpanzeesP E Rao, G Olini, J Kille, et al.
Cancer|October 1, 1979
High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaS A Rudnick, E C Cadman, R L Capizzi, et al.
Gastrointestinal Endoscopy|November 1, 1982
Use of the flexible sigmoidoscope in women with previous pelvic irradiationR S Sandler, V Varma, C A Herbst, et al.
The New England Journal of Medicine|July 24, 1980
Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factorsP A Aronin, M S Mahaley, S A Rudnick, et al.
Cancer|March 15, 1983
High-dose methotrexate in small cell lung cancer. Lack of efficacy in preventing CNS relapseE S Neijstrom, R L Capizzi, S A Rudnick, et al.
Pageof 3